Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze

Muscarinic acetylcholine (ACh) systems have long been known to be necessary for accurate performance in cognitive tests. Nicotinic ACh systems have been shown to be involved as well. However, there is only a limited amount of information concerning the interactions of these two branches of the ACh transmitter system. The current study was conducted to investigate the improvement in choice accuracy caused by muscarinic and nicotinic agonists and how it is affected by antagonists of these systems. Adult female Sprague-Dawley strain rats (N = 11) were trained on a working memory task in an 8-arm radial maze. Acute injections of the muscarinic and nicotinic agonists, pilocarpine (PILO, 1.0 mg/kg) and nicotine (NIC, 0.2 mg/kg), were made alone or in combination with the muscarinic and nicotinic antagonists, scopolamine (SCOP, 0.1 mg/kg) and mecamylamine (MEC, 10 mg/kg). NIC administration caused a significant improvement in choice accuracy compared with saline (p less than 0.01) and PILO caused a marginally significant improvement in choice accuracy (p less than 0.06). The combination of these nicotinic and muscarinic agonists did not cause an additive improvement. However, the improvement caused by either agonist was reversed by both nicotinic or muscarinic antagonists. This reversal was more complete for NIC than PILO despite the fact that NIC caused a greater improvement than PILO. These results suggest that muscarinic and nicotinic components of the ACh system, which are both important for cognitive function, interact in important ways. These interactions may be critical to consider when devising treatments for cognitive dysfunction associated with cholinergic hypofunction such as with Alzheimer's disease.

[1]  R. Russell,et al.  Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP. , 1974, Pharmacology, biochemistry, and behavior.

[2]  G. Lunt,et al.  Presynaptic modulation of transmitter release by nicotinic receptors. , 1989, Progress in brain research.

[3]  P. Rowell,et al.  Nicotinic Stimulation of [3H]Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes , 1984, Journal of neurochemistry.

[4]  M. E. Goldberg,et al.  Learning impairment after three classes of agents which modify cholinergic function. , 1971, Archives internationales de pharmacodynamie et de therapie.

[5]  E. T. Iwamoto Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. , 1989, The Journal of pharmacology and experimental therapeutics.

[6]  P. Whitehouse Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. , 1987, Advances in neurology.

[7]  E. Levin,et al.  Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. , 1990, Behavioral and neural biology.

[8]  Bengt Winblad,et al.  Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains , 1986, Neuroscience Letters.

[9]  L. Jarrard,et al.  Scopolamine impairs performance of a place and cue task in rats. , 1982, Behavioral and neural biology.

[10]  L. Butcher,et al.  Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. , 1989, Behavioral and neural biology.

[11]  L. Ferraro,et al.  Effect of nicotine on the release of acetylcholine and amino acids in the brain. , 1989, Progress in brain research.

[12]  R. Stevens Scopolamine impairs spatial maze performance in rats , 1981, Physiology & Behavior.

[13]  Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. , 1969, Archives internationales de pharmacodynamie et de therapie.

[14]  J. Coyle,et al.  Nicotinic acetylcholine binding sites in Alzheimer's disease , 1986, Brain Research.

[15]  L. Butcher,et al.  Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. , 1990, Behavioral and neural biology.

[16]  R. Beninger,et al.  Differential effects of scopolamine on working and reference memory of rats in the radial maze , 1984, Pharmacology Biochemistry and Behavior.

[17]  E. Levin Psychopharmacological effects in the radial-arm maze , 1988, Neuroscience & Biobehavioral Reviews.

[18]  S. L. Dilts Berry CA: Effect of cholinergic drugs on passive avoidance in the mouse. , 1967, The Journal of pharmacology and experimental therapeutics.

[19]  B. Martin,et al.  What is the nature of mecamylamine's antagonism of the central effects of nicotine? , 1989, Biochemical pharmacology.

[20]  A. Oliverio Effects of mecamylamine on avoidance conditioning and maze learning of mice. , 1966, The Journal of pharmacology and experimental therapeutics.

[21]  E. Levin,et al.  Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. , 1990, Behavioural pharmacology.

[22]  J. Sirviö,et al.  Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning , 1990, Pharmacology Biochemistry and Behavior.

[23]  R. Stevens,et al.  Effects of scopolamine on radial maze performance in rats , 1981, Physiology & Behavior.

[24]  E D Levin,et al.  Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. , 1987, Behavioral and neural biology.